Use of levosimendan or pharmaceutically acceptable salt thereof for the manufacture of a medicament for the treatment of pulmonary hypertension

摘要

Use of levosimendan, or (-)-[[4-(1,4,5,6-tetrahydro-4- methyl-6-oxopyridazin-3-yl)phenyl]hydrazono]propanedinitrile, or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the treatment of pulmonary hypertension.